Skip to main content
Log in

The effect of conjugated equine estrogens on ovariectomy-induced osteopenia in the rat

  • Inflammation and Immunomodulation
  • Letters to the Editors
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The effect of estrogen replacement on ovariectomy-induced bone loss was evaluated in mature Sprague-Dawley rats. Undecalcified tibia of ovariectomized rats were processed for quantitative histologic assessment of cancellous bone in longitudinal sections from the primary and secondary spongiosa of the proximal metaphysis. Bone content in tissue specimens was quantified as the parameter B. Ar, two-dimensional bone mineral area. Estrogen, supplied as orally administered conjugated equine estrogens, prevented bone loss through 6 weeks of treatment. The effect of conjugated equine estrogens was dose-dependent, with significant protection against bone loss observed at doses of 10 μg/kg/day and higher.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. R. Lindsay, D. M. Hart and D. M. Clark,The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstetrics and Gynecology63, 759–763 (1984).

    PubMed  Google Scholar 

  2. B. Ettinger, H. K. Genant and C. E. Cann,Long-term estrogen replacement therapy prevents bone loss and fractures. Ann. Int. Med.102, 319–324 (1985).

    PubMed  Google Scholar 

  3. F. W. Lafferty and D. O. Helmuth,Post-menopausal estrogen replacement: the prevention of osteoporosis and systemic effects. Maturitas,7, 147–159 (1985).

    PubMed  Google Scholar 

  4. W. A. Peck,Osteoporosis consensus conference. J. Am. Med. Assoc.252, 799–802 (1984).

    Google Scholar 

  5. J. M. Altken, E. Armstrong and J. B. Armstrong,Osteoporosis after oophorectomy in the mature female rat and the effect of estrogen and/or progestagen replacement therapy in its prevention. J. Endocrinol.55, 79–87 (1972).

    PubMed  Google Scholar 

  6. D. N. Kalu,Evaluation of the pathogenesis of skeletal changes in ovariectomized rats. Endocrinology115, 507–512 (1984).

    PubMed  Google Scholar 

  7. U. S. Barzel,Studies in osteoporosis: The long-term effect of oophorectomy and of ammonium chloride ingestion on the bone of mature rats. Endocrinology96, 1304–1306 (1975).

    PubMed  Google Scholar 

  8. T. J. Wronski, P. L. Lowry, C. C. Walsh and L. A. Ignaszewski,Skeletal alterations in ovariectomized rats. Calcif. Tiss. Int.37, 324–328 (1985).

    Google Scholar 

  9. T. J. Wronski, C. C. Walsh and L. A. Ignaszewski,Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone7, 119–123 (1986).

    PubMed  Google Scholar 

  10. R. T. Turner, J. J. Vandersteenhaven and N. H. Bell,The effects of ovariectomy and 17-β estradiol on cortical bone histomorphometry in growing rats, J. Bone Min. Res.2, 115–122 (1987).

    Google Scholar 

  11. R. T. Turner, G. K. Wakley, K. S. Hannon and N. H. Bell,Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats. J. Bone Min. Res.2, 449–456 (1987).

    Google Scholar 

  12. R. T. Turner, G. K. Wakley, K. S. Hannon and N. H. Bell,Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats. Endocrinology122, 1146–1150 (1988).

    PubMed  Google Scholar 

  13. T. J. Wronski, M. Clintron, A. L. Doherty and L. M. Dann,Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology123, 681–686 (1988).

    PubMed  Google Scholar 

  14. H. E. Gruber, G. J. Marshall, M. E. Kirchon, J. Kang and S. G. Massry,Improvements in dehydration and cement line staining for methacrylate embedded human bone biopsies. Stain Technology60, 337–344 (1986).

    Google Scholar 

  15. R. R. ReckerBone histomorphometry: techniques and interpretation. CRC Press, 1983, Boca Raton, Fla. (The modification of this standard technique entails staining free-floating sections, and omitting the hematoxylin step from the staining protocol as per personal communication with Drs. G. A. Howard and C. C. Liu at the American Lake V.A. Medical Center, Tacoma WA).

    Google Scholar 

  16. A. M. Parfitt (chairman;Report of the ASBMR Histomorphometry nomenclature committee), Bone histomorphometry: standardization of nomenclature, symbols and units. J. Bone Min. Res.2, 595–610 (1987).

    Google Scholar 

  17. A. M. Parfitt,Trabecular bone architecture in the pathogeneses and prevention of fracture. Am. J. Med.82, 68–72 (1987).

    Google Scholar 

  18. D. P. Kiel, D. T. Felson, J. J. Anderson, P. W. F. Wilson and M. A. Miskowitz,Hip fracture and the use of estrogens in postmenopausal women. N. Engl. J. Med.317, 1169–1174 (1987).

    PubMed  Google Scholar 

  19. H. M. Frost,The skeletal intermediary organization. Metab. Bone Dis. & Rel. Res.4, 218–290 (1983).

    Google Scholar 

  20. S. Bernick,Histochemical study of bone in gonadectomized rats. Calcif. Tiss. Res.5, 170–182 (1970).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayward, M.A., Kharode, Y.P., Becci, M.M. et al. The effect of conjugated equine estrogens on ovariectomy-induced osteopenia in the rat. Agents and Actions 31, 152–156 (1990). https://doi.org/10.1007/BF02003236

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02003236

Keywords

Navigation